The azithromycin to prevent wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population

Severe respiratory syncytial virus (RSV) bronchiolitis in early life is a significant risk factor for future recurrent wheeze (RW) and asthma. The goal of the Azithromycin to Prevent Wheezing following severe RSV bronchiolitis II (APW-RSV II) clinical trial is to evaluate if azithromycin treatment i...

Descripción completa

Detalles Bibliográficos
Autores principales: Srinivasan, Mythili, Bacharier, Leonard B., Goss, Charles W., Zhou, Yanjiao, Boomer, Jonathan, Bram, Sarah, Burgdorf, Dana, Burnham, Carey-Ann, Casper, Timothy, Castro, Mario, Coverstone, Andrea, Haslam, Matthew, Kanchongkittiphon, Watcharoot, Kuklinski, Cadence, Lian, Qinghua, Schechtman, Kenneth, Storch, Gregory A., True, Kelly, Wallace, Meghan A., Yin-DeClue, Huiqing, Ahrens, Elizabeth, Wang, Jinli, Beigelman, Avraham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219746/
https://www.ncbi.nlm.nih.gov/pubmed/34189338
http://dx.doi.org/10.1016/j.conctc.2021.100798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219746/
https://www.ncbi.nlm.nih.gov/pubmed/34189338
http://dx.doi.org/10.1016/j.conctc.2021.100798

Ejemplares similares